Devices & Medtech

For many years, we have advised Smith & Nephew, one of the world’s leading medical devices and medical technology companies. Our work has included patent litigation in relation to wound healing products and technology, M&A, regulatory advice, and procurement of IT and digital technologies and services.

Our client, a leading healthcare provider, wanted to offer its patients a seamless digital service to access their medical information, book appointments and manage their payments. We supported our client’s initial investment into the Silicon Valley start-up it was partnering with, advised on IP licensing and IT hosting arrangements, as well as data protection and regulatory compliance.

Advising Genomics England (GEL) on the 100,000 Genome Project, a project backed by the UK Government to sequence the DNA of 100,000 NHS patients.  Over more than five years, we have advised GEL on its IP and commercialisation strategy for implementing the largest sequencing project in the world and led negotiations for the various data, IT, technology and IP commercialisation projects, as well as assisting on real estate transactions to house the sequencing and technology hardware and providing employment and corporate advisory services to the organisation.

We advised ResMed, the world’s leading manufacturer of medical respiratory devices, in defence of UK revocation proceedings brought by a significant competitor in relation to three of ResMed’s patents. The dispute related to products for diagnosing and treating sleep-related respiratory disorders and involved our coordinating parallel litigation in nine jurisdictions.

Our client, one of the most high-profile creators of artificial intelligence in the world, regularly seeks our advice in connection with regulatory compliance for novel products in the healthcare arena.